Clearstead Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.19K | Sell |
21
-77
| -79% | -$11.7K | ﹤0.01% | 2222 |
|
|
2025
Q1 | $14.8K | Sell |
98
-1,023
| -91% | -$154K | ﹤0.01% | 1496 |
|
|
2024
Q4 | $207K | Sell |
1,121
-13
| -1% | -$2.4K | ﹤0.01% | 843 |
|
|
2024
Q3 | $223K | Sell |
1,134
-47
| -4% | -$9.26K | ﹤0.01% | 822 |
|
|
2024
Q2 | $244K | Buy |
1,181
+1,062
| +892% | +$219K | ﹤0.01% | 751 |
|
|
2024
Q1 | $27.2K | Buy |
119
+9
| +8% | +$2.06K | ﹤0.01% | 890 |
|
|
2023
Q4 | $26K | Buy |
110
+48
| +77% | +$11.3K | ﹤0.01% | 892 |
|
|
2023
Q3 | $12.2K | Buy |
62
+52
| +520% | +$10.2K | ﹤0.01% | 1089 |
|
|
2023
Q2 | $2.1K | Sell |
10
-95
| -90% | -$20K | ﹤0.01% | 1137 |
|
|
2023
Q1 | $21.2K | Buy |
105
+18
| +21% | +$3.63K | ﹤0.01% | 846 |
|
|
2022
Q4 | $19K | Buy |
87
+10
| +13% | +$2.18K | ﹤0.01% | 807 |
|
|
2022
Q3 | $15K | Hold |
77
| – | – | ﹤0.01% | 814 |
|
|
2022
Q2 | $16K | Hold |
77
| – | – | ﹤0.01% | 841 |
|
|
2022
Q1 | $22K | Hold |
77
| – | – | ﹤0.01% | 839 |
|
|
2021
Q4 | $29K | Hold |
77
| – | – | ﹤0.01% | 738 |
|
|
2021
Q3 | $32K | Buy |
+77
| New | +$32K | ﹤0.01% | 682 |
|